Breath analyzers

Chronicle

2024: Global Breath Analyzers Market Size Reaches $743 Million for the Year

In 2025, sales of breath analyzers, including breathalysers, globally amounted to $742.9 million. Almost 40% of this amount fell on the North American region. Such data are presented in a Fortune Business Insights study, the results of which are presented on December 18, 2025.

Breath analyzers are medical, laboratory and household appliances that measure various components of exhaled air. Such devices are used to diagnose various conditions, assess metabolism and determine the presence of certain substances, such as alcohol vapors, hydrogen, methane or specific volatile organic compounds associated with certain diseases.

𝓲

Фото: Freepik

One of the key drivers of the market in question is the growing demand for breath analyzers in the area. health care Such devices are used to diagnose pulmonary diseases - bronchial asthma, chronic obstructive pulmonary disease (), COPD chronic cough, rhinitis, sinusitis and other pathologies of the respiratory tract. Analyzers help in monitoring the condition of patients with severe respiratory disorders. The devices can be used to control inflammation in the airways, diagnose obstructive sleep apnea syndrome and assess nocturnal hypoxia, control lung and respiratory function in athletes, etc. Special hydrogen analyzers diagnose lactose, fructose intolerance, bacterial overgrowth syndrome and absorption disorders by measuring hydrogen and methane concentrations. The use of exhalation analysis to detect disease biomarkers enables the formation of personalized treatment strategies.

The authors of the study also point to an increase in sales of breathalysers to identify drunk drivers. This is due to the tightening of legislation and an increase in the number of road accidents involving motorists while intoxicated. In addition, there is an increase in driving culture: many drivers purchase breathalysers for self-control.

Technological advances have a positive impact on the industry. We are talking about the introduction of sensors based on nanotechnology and the development of more compact, accurate and affordable devices for various applications. The integration of artificial intelligence improves the speed and efficiency of data analysis.

Depending on analyzer design, the market is segmented into portable/manual and stationary/desktop devices. In 2025, the largest share of revenue was provided by the first type of solutions. At the same time, the direction of medical diagnostics dominates. From a geographical point of view, the most significant contribution is made by North America - 39.3%, or $291.6 million. The United States accounted for $267.4 million, Europe - $207.3 million, Asia-Pacific - $205.4 million. Sales in Latin America are estimated at about $23 million. The rest of the revenue was provided by the countries of the Middle East and Africa. Major industry players on a global scale are:

• Drägerwerk AG & Co. KGaA;
• Lifeloc Technologies;
• BACtrack;
• Intoximeters;
• Alcohol Countermeasure Systems;
• Abbott;
• Alcolizer;
• Owlstone Medical;
• Lion Laboratories;
• Avalon GloboCare.

The global breath analyzer market is expected to reach $781.9 million in 2026. Fortune Business Insights analysts forecast a compound percentage CAGR of 6.9% going forward. Thus, by 2034, costs may increase to $1.33 billion.^[1]

Notes